FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Sun Pharmaceutical Industries Children's Cetirizine Hydrochloride Chewable Recall

Children's Cetirizine Hydrochloride Chewable Tablets, 5 mg, 30-count bottle, Manufactur…

Sun Pharmaceutical Industries, Inc. · Cranbury, NJ

Risk level
Class III
Reported by FDA
May 31, 2017
Recall ID
D-0857-2017
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled Children's Cetirizine Hydrochloride Chewable starting Apr 18, 2017. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0857-2017 on May 31, 2017. Reason: Failed Tablet/Capsule Specifications: out of specification results for increased tablet hardness. Status: Terminated.

Why it was recalled

Failed Tablet/Capsule Specifications: out of specification results for increased tablet hardness.

Product description

Children's Cetirizine Hydrochloride Chewable Tablets, 5 mg, 30-count bottle, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol - 389 350, Gujarat, India; Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 47335-343-83.

Lot numbers, UPCs & expiration codes

Lot #: JKR5135A, Exp 11/17

Where it was sold

Nationwide in the USA and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0857-2017
Classification
Class III
Status
Terminated
Recall initiated
Apr 18, 2017
FDA report date
May 31, 2017
Quantity
13,200 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Sun Pharmaceutical Industries, Inc.

Original FDA data

Every field from FDA enforcement report D-0857-2017, exactly as published.

Show all FDA fields
City
Cranbury
State
NJ
Status
Terminated
Country
United States
Event ID
77103
Address
270 Prospect Plains Rd
Code information
Lot #: JKR5135A, Exp 11/17
Postal code
08512-3605
Report date
May 31, 2017
Product type
Drugs
Recall number
D-0857-2017
Classification
Class III
Recalling firm
Sun Pharmaceutical Industries, Inc.
Product quantity
13,200 bottles
Termination date
May 18, 2018
Reason for recall
Failed Tablet/Capsule Specifications: out of specification results for increased tablet hardness.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Children's Cetirizine Hydrochloride Chewable Tablets, 5 mg, 30-count bottle, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol - 389 350, Gujarat, India; Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 47335-343-83.
Distribution pattern
Nationwide in the USA and Puerto Rico
Recall initiation date
Apr 18, 2017
Initial firm notification
Letter
Center classification date
May 23, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0857-2017, published May 31, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls